Global mRNA Therapy Market Research Report 2023

Global mRNA Therapy Market Research Report 2023

Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global mRNA Therapy Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Vaccine
1.2.3 Drugs
1.3 Market by Application
1.3.1 Global mRNA Therapy Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 mRNA Targeted Delivery in vivo
1.3.3 Genetically Modified T cells
1.3.4 Transforming Nanoparticles to Develop Immunotherapy for Cancer
1.3.5 Small Molecule Drugs Discovery
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global mRNA Therapy Market Perspective (2018-2029)
2.2 mRNA Therapy Growth Trends by Region
2.2.1 Global mRNA Therapy Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 mRNA Therapy Historic Market Size by Region (2018-2023)
2.2.3 mRNA Therapy Forecasted Market Size by Region (2024-2029)
2.3 mRNA Therapy Market Dynamics
2.3.1 mRNA Therapy Industry Trends
2.3.2 mRNA Therapy Market Drivers
2.3.3 mRNA Therapy Market Challenges
2.3.4 mRNA Therapy Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top mRNA Therapy Players by Revenue
3.1.1 Global Top mRNA Therapy Players by Revenue (2018-2023)
3.1.2 Global mRNA Therapy Revenue Market Share by Players (2018-2023)
3.2 Global mRNA Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by mRNA Therapy Revenue
3.4 Global mRNA Therapy Market Concentration Ratio
3.4.1 Global mRNA Therapy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by mRNA Therapy Revenue in 2022
3.5 mRNA Therapy Key Players Head office and Area Served
3.6 Key Players mRNA Therapy Product Solution and Service
3.7 Date of Enter into mRNA Therapy Market
3.8 Mergers & Acquisitions, Expansion Plans
4 mRNA Therapy Breakdown Data by Type
4.1 Global mRNA Therapy Historic Market Size by Type (2018-2023)
4.2 Global mRNA Therapy Forecasted Market Size by Type (2024-2029)
5 mRNA Therapy Breakdown Data by Application
5.1 Global mRNA Therapy Historic Market Size by Application (2018-2023)
5.2 Global mRNA Therapy Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America mRNA Therapy Market Size (2018-2029)
6.2 North America mRNA Therapy Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America mRNA Therapy Market Size by Country (2018-2023)
6.4 North America mRNA Therapy Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe mRNA Therapy Market Size (2018-2029)
7.2 Europe mRNA Therapy Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe mRNA Therapy Market Size by Country (2018-2023)
7.4 Europe mRNA Therapy Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific mRNA Therapy Market Size (2018-2029)
8.2 Asia-Pacific mRNA Therapy Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific mRNA Therapy Market Size by Region (2018-2023)
8.4 Asia-Pacific mRNA Therapy Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America mRNA Therapy Market Size (2018-2029)
9.2 Latin America mRNA Therapy Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America mRNA Therapy Market Size by Country (2018-2023)
9.4 Latin America mRNA Therapy Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa mRNA Therapy Market Size (2018-2029)
10.2 Middle East & Africa mRNA Therapy Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa mRNA Therapy Market Size by Country (2018-2023)
10.4 Middle East & Africa mRNA Therapy Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Moderna
11.1.1 Moderna Company Detail
11.1.2 Moderna Business Overview
11.1.3 Moderna mRNA Therapy Introduction
11.1.4 Moderna Revenue in mRNA Therapy Business (2018-2023)
11.1.5 Moderna Recent Development
11.2 BioNTech
11.2.1 BioNTech Company Detail
11.2.2 BioNTech Business Overview
11.2.3 BioNTech mRNA Therapy Introduction
11.2.4 BioNTech Revenue in mRNA Therapy Business (2018-2023)
11.2.5 BioNTech Recent Development
11.3 Pfizer
11.3.1 Pfizer Company Detail
11.3.2 Pfizer Business Overview
11.3.3 Pfizer mRNA Therapy Introduction
11.3.4 Pfizer Revenue in mRNA Therapy Business (2018-2023)
11.3.5 Pfizer Recent Development
11.4 Arcturus Therapeutics Holdings Inc.
11.4.1 Arcturus Therapeutics Holdings Inc. Company Detail
11.4.2 Arcturus Therapeutics Holdings Inc. Business Overview
11.4.3 Arcturus Therapeutics Holdings Inc. mRNA Therapy Introduction
11.4.4 Arcturus Therapeutics Holdings Inc. Revenue in mRNA Therapy Business (2018-2023)
11.4.5 Arcturus Therapeutics Holdings Inc. Recent Development
11.5 Astrazeneca
11.5.1 Astrazeneca Company Detail
11.5.2 Astrazeneca Business Overview
11.5.3 Astrazeneca mRNA Therapy Introduction
11.5.4 Astrazeneca Revenue in mRNA Therapy Business (2018-2023)
11.5.5 Astrazeneca Recent Development
11.6 CureVac
11.6.1 CureVac Company Detail
11.6.2 CureVac Business Overview
11.6.3 CureVac mRNA Therapy Introduction
11.6.4 CureVac Revenue in mRNA Therapy Business (2018-2023)
11.6.5 CureVac Recent Development
11.7 Translate Bio
11.7.1 Translate Bio Company Detail
11.7.2 Translate Bio Business Overview
11.7.3 Translate Bio mRNA Therapy Introduction
11.7.4 Translate Bio Revenue in mRNA Therapy Business (2018-2023)
11.7.5 Translate Bio Recent Development
11.8 Regeneron Pharmaceuticals
11.8.1 Regeneron Pharmaceuticals Company Detail
11.8.2 Regeneron Pharmaceuticals Business Overview
11.8.3 Regeneron Pharmaceuticals mRNA Therapy Introduction
11.8.4 Regeneron Pharmaceuticals Revenue in mRNA Therapy Business (2018-2023)
11.8.5 Regeneron Pharmaceuticals Recent Development
11.9 Arcturus Therapeutics
11.9.1 Arcturus Therapeutics Company Detail
11.9.2 Arcturus Therapeutics Business Overview
11.9.3 Arcturus Therapeutics mRNA Therapy Introduction
11.9.4 Arcturus Therapeutics Revenue in mRNA Therapy Business (2018-2023)
11.9.5 Arcturus Therapeutics Recent Development
11.10 Takeda Pharmaceutical Company
11.10.1 Takeda Pharmaceutical Company Company Detail
11.10.2 Takeda Pharmaceutical Company Business Overview
11.10.3 Takeda Pharmaceutical Company mRNA Therapy Introduction
11.10.4 Takeda Pharmaceutical Company Revenue in mRNA Therapy Business (2018-2023)
11.10.5 Takeda Pharmaceutical Company Recent Development
11.11 Novartis
11.11.1 Novartis Company Detail
11.11.2 Novartis Business Overview
11.11.3 Novartis mRNA Therapy Introduction
11.11.4 Novartis Revenue in mRNA Therapy Business (2018-2023)
11.11.5 Novartis Recent Development
11.12 Sanofi
11.12.1 Sanofi Company Detail
11.12.2 Sanofi Business Overview
11.12.3 Sanofi mRNA Therapy Introduction
11.12.4 Sanofi Revenue in mRNA Therapy Business (2018-2023)
11.12.5 Sanofi Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global mRNA Therapy Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029
Table 2. Key Players of Vaccine
Table 3. Key Players of Drugs
Table 4. Global mRNA Therapy Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029
Table 5. Global mRNA Therapy Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 6. Global mRNA Therapy Market Size by Region (2018-2023) & (US$ Million)
Table 7. Global mRNA Therapy Market Share by Region (2018-2023)
Table 8. Global mRNA Therapy Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 9. Global mRNA Therapy Market Share by Region (2024-2029)
Table 10. mRNA Therapy Market Trends
Table 11. mRNA Therapy Market Drivers
Table 12. mRNA Therapy Market Challenges
Table 13. mRNA Therapy Market Restraints
Table 14. Global mRNA Therapy Revenue by Players (2018-2023) & (US$ Million)
Table 15. Global mRNA Therapy Market Share by Players (2018-2023)
Table 16. Global Top mRNA Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in mRNA Therapy as of 2022)
Table 17. Ranking of Global Top mRNA Therapy Companies by Revenue (US$ Million) in 2022
Table 18. Global 5 Largest Players Market Share by mRNA Therapy Revenue (CR5 and HHI) & (2018-2023)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players mRNA Therapy Product Solution and Service
Table 21. Date of Enter into mRNA Therapy Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global mRNA Therapy Market Size by Type (2018-2023) & (US$ Million)
Table 24. Global mRNA Therapy Revenue Market Share by Type (2018-2023)
Table 25. Global mRNA Therapy Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 26. Global mRNA Therapy Revenue Market Share by Type (2024-2029)
Table 27. Global mRNA Therapy Market Size by Application (2018-2023) & (US$ Million)
Table 28. Global mRNA Therapy Revenue Market Share by Application (2018-2023)
Table 29. Global mRNA Therapy Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 30. Global mRNA Therapy Revenue Market Share by Application (2024-2029)
Table 31. North America mRNA Therapy Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 32. North America mRNA Therapy Market Size by Country (2018-2023) & (US$ Million)
Table 33. North America mRNA Therapy Market Size by Country (2024-2029) & (US$ Million)
Table 34. Europe mRNA Therapy Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 35. Europe mRNA Therapy Market Size by Country (2018-2023) & (US$ Million)
Table 36. Europe mRNA Therapy Market Size by Country (2024-2029) & (US$ Million)
Table 37. Asia-Pacific mRNA Therapy Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029
Table 38. Asia-Pacific mRNA Therapy Market Size by Region (2018-2023) & (US$ Million)
Table 39. Asia-Pacific mRNA Therapy Market Size by Region (2024-2029) & (US$ Million)
Table 40. Latin America mRNA Therapy Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 41. Latin America mRNA Therapy Market Size by Country (2018-2023) & (US$ Million)
Table 42. Latin America mRNA Therapy Market Size by Country (2024-2029) & (US$ Million)
Table 43. Middle East & Africa mRNA Therapy Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 44. Middle East & Africa mRNA Therapy Market Size by Country (2018-2023) & (US$ Million)
Table 45. Middle East & Africa mRNA Therapy Market Size by Country (2024-2029) & (US$ Million)
Table 46. Moderna Company Detail
Table 47. Moderna Business Overview
Table 48. Moderna mRNA Therapy Product
Table 49. Moderna Revenue in mRNA Therapy Business (2018-2023) & (US$ Million)
Table 50. Moderna Recent Development
Table 51. BioNTech Company Detail
Table 52. BioNTech Business Overview
Table 53. BioNTech mRNA Therapy Product
Table 54. BioNTech Revenue in mRNA Therapy Business (2018-2023) & (US$ Million)
Table 55. BioNTech Recent Development
Table 56. Pfizer Company Detail
Table 57. Pfizer Business Overview
Table 58. Pfizer mRNA Therapy Product
Table 59. Pfizer Revenue in mRNA Therapy Business (2018-2023) & (US$ Million)
Table 60. Pfizer Recent Development
Table 61. Arcturus Therapeutics Holdings Inc. Company Detail
Table 62. Arcturus Therapeutics Holdings Inc. Business Overview
Table 63. Arcturus Therapeutics Holdings Inc. mRNA Therapy Product
Table 64. Arcturus Therapeutics Holdings Inc. Revenue in mRNA Therapy Business (2018-2023) & (US$ Million)
Table 65. Arcturus Therapeutics Holdings Inc. Recent Development
Table 66. Astrazeneca Company Detail
Table 67. Astrazeneca Business Overview
Table 68. Astrazeneca mRNA Therapy Product
Table 69. Astrazeneca Revenue in mRNA Therapy Business (2018-2023) & (US$ Million)
Table 70. Astrazeneca Recent Development
Table 71. CureVac Company Detail
Table 72. CureVac Business Overview
Table 73. CureVac mRNA Therapy Product
Table 74. CureVac Revenue in mRNA Therapy Business (2018-2023) & (US$ Million)
Table 75. CureVac Recent Development
Table 76. Translate Bio Company Detail
Table 77. Translate Bio Business Overview
Table 78. Translate Bio mRNA Therapy Product
Table 79. Translate Bio Revenue in mRNA Therapy Business (2018-2023) & (US$ Million)
Table 80. Translate Bio Recent Development
Table 81. Regeneron Pharmaceuticals Company Detail
Table 82. Regeneron Pharmaceuticals Business Overview
Table 83. Regeneron Pharmaceuticals mRNA Therapy Product
Table 84. Regeneron Pharmaceuticals Revenue in mRNA Therapy Business (2018-2023) & (US$ Million)
Table 85. Regeneron Pharmaceuticals Recent Development
Table 86. Arcturus Therapeutics Company Detail
Table 87. Arcturus Therapeutics Business Overview
Table 88. Arcturus Therapeutics mRNA Therapy Product
Table 89. Arcturus Therapeutics Revenue in mRNA Therapy Business (2018-2023) & (US$ Million)
Table 90. Arcturus Therapeutics Recent Development
Table 91. Takeda Pharmaceutical Company Company Detail
Table 92. Takeda Pharmaceutical Company Business Overview
Table 93. Takeda Pharmaceutical Company mRNA Therapy Product
Table 94. Takeda Pharmaceutical Company Revenue in mRNA Therapy Business (2018-2023) & (US$ Million)
Table 95. Takeda Pharmaceutical Company Recent Development
Table 96. Novartis Company Detail
Table 97. Novartis Business Overview
Table 98. Novartis mRNA Therapy Product
Table 99. Novartis Revenue in mRNA Therapy Business (2018-2023) & (US$ Million)
Table 100. Novartis Recent Development
Table 101. Sanofi Company Detail
Table 102. Sanofi Business Overview
Table 103. Sanofi mRNA Therapy Product
Table 104. Sanofi Revenue in mRNA Therapy Business (2018-2023) & (US$ Million)
Table 105. Sanofi Recent Development
Table 106. Research Programs/Design for This Report
Table 107. Key Data Information from Secondary Sources
Table 108. Key Data Information from Primary Sources
List of Figures
Figure 1. Global mRNA Therapy Market Size Comparison by Type (2023-2029) & (US$ Million)
Figure 2. Global mRNA Therapy Market Share by Type: 2022 VS 2029
Figure 3. Vaccine Features
Figure 4. Drugs Features
Figure 5. Global mRNA Therapy Market Size Comparison by Application (2023-2029) & (US$ Million)
Figure 6. Global mRNA Therapy Market Share by Application: 2022 VS 2029
Figure 7. mRNA Targeted Delivery in vivo Case Studies
Figure 8. Genetically Modified T cells Case Studies
Figure 9. Transforming Nanoparticles to Develop Immunotherapy for Cancer Case Studies
Figure 10. Small Molecule Drugs Discovery Case Studies
Figure 11. mRNA Therapy Report Years Considered
Figure 12. Global mRNA Therapy Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 13. Global mRNA Therapy Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 14. Global mRNA Therapy Market Share by Region: 2022 VS 2029
Figure 15. Global mRNA Therapy Market Share by Players in 2022
Figure 16. Global Top mRNA Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in mRNA Therapy as of 2022)
Figure 17. The Top 10 and 5 Players Market Share by mRNA Therapy Revenue in 2022
Figure 18. North America mRNA Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 19. North America mRNA Therapy Market Share by Country (2018-2029)
Figure 20. United States mRNA Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 21. Canada mRNA Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 22. Europe mRNA Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 23. Europe mRNA Therapy Market Share by Country (2018-2029)
Figure 24. Germany mRNA Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 25. France mRNA Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 26. U.K. mRNA Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 27. Italy mRNA Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 28. Russia mRNA Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. Nordic Countries mRNA Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. Asia-Pacific mRNA Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. Asia-Pacific mRNA Therapy Market Share by Region (2018-2029)
Figure 32. China mRNA Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. Japan mRNA Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. South Korea mRNA Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 35. Southeast Asia mRNA Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 36. India mRNA Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 37. Australia mRNA Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 38. Latin America mRNA Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 39. Latin America mRNA Therapy Market Share by Country (2018-2029)
Figure 40. Mexico mRNA Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 41. Brazil mRNA Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 42. Middle East & Africa mRNA Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 43. Middle East & Africa mRNA Therapy Market Share by Country (2018-2029)
Figure 44. Turkey mRNA Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 45. Saudi Arabia mRNA Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 46. Moderna Revenue Growth Rate in mRNA Therapy Business (2018-2023)
Figure 47. BioNTech Revenue Growth Rate in mRNA Therapy Business (2018-2023)
Figure 48. Pfizer Revenue Growth Rate in mRNA Therapy Business (2018-2023)
Figure 49. Arcturus Therapeutics Holdings Inc. Revenue Growth Rate in mRNA Therapy Business (2018-2023)
Figure 50. Astrazeneca Revenue Growth Rate in mRNA Therapy Business (2018-2023)
Figure 51. CureVac Revenue Growth Rate in mRNA Therapy Business (2018-2023)
Figure 52. Translate Bio Revenue Growth Rate in mRNA Therapy Business (2018-2023)
Figure 53. Regeneron Pharmaceuticals Revenue Growth Rate in mRNA Therapy Business (2018-2023)
Figure 54. Arcturus Therapeutics Revenue Growth Rate in mRNA Therapy Business (2018-2023)
Figure 55. Takeda Pharmaceutical Company Revenue Growth Rate in mRNA Therapy Business (2018-2023)
Figure 56. Novartis Revenue Growth Rate in mRNA Therapy Business (2018-2023)
Figure 57. Sanofi Revenue Growth Rate in mRNA Therapy Business (2018-2023)
Figure 58. Bottom-up and Top-down Approaches for This Report
Figure 59. Data Triangulation
Figure 60. Key Executives Interviewed

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Nuclear Medicine Cyclotron Systems Market Report, History and Forecast 2018-2029

Published: 11-Jan-2024        Price: US 3350 Onwards        Pages: 118

The global Nuclear Medicine Cyclotron Systems market was valued at US$ 220.85 million in 2022 and will reach US$ 283.75 million by the end of 2029, growing at a CAGR of 4.38% during 2023-2029. Asia-Pacific market for Nuclear Medicine Cyclotron Systems was valued at $ 61.16 million in 2022 and will reach $ 104.22 million by 2029, at a CAGR of 5.84% during the forecast period of 2023 through 2029. Report Scope This report aims to provide a comprehensive presentation of the glo......

Global Non-imaging Diagnostic Catheter Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 95

The global Non-imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......

Global Imaging Diagnostic Catheter Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 90

The global Imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estimated......

Global PCR Equipment Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 77

The global PCR Equipment market was valued at US$ 806 million in 2023 and is anticipated to reach US$ 1230.7 million by 2030, witnessing a CAGR of 6.7% during The forecast period 2024-2030. PCR (Polymerase Chain Reaction) equipment is widely used in molecular biology and genetics research for amplifying DNA and RNA sequences. The market for PCR equipment is influenced by several key drivers. Here are some of The significant market drivers: Advancements in Research and Diagnost......

Global Disposable Sterile Syringes and Needles Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 109

The global Disposable Sterile Syringes and Needles market was valued at US$ 404.4 million in 2023 and is anticipated to reach US$ 539.1 million by 2030, witnessing a CAGR of 2.1% during The forecast period 2024-2030. North American market for Disposable Sterile Syringes and Needles is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Disposable Sterile Syringes and N......

Global Orthopaedic Power Tools Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106

The global Orthopaedic Power Tools market was valued at US$ 463.3 million in 2023 and is anticipated to reach US$ 746.5 million by 2030, witnessing a CAGR of 7.3% during The forecast period 2024-2030. North American market for Orthopaedic Power Tools is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Orthopaedic Power Tools is estimated to increase from $ million i......

Global Cerebrospinal Fluid Management Devices Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86

The global Cerebrospinal Fluid Management Devices market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Cerebrospinal Fluid Management Devices is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Cerebrospinal Fluid Management Devices is estimate......

Global CAD & CAM Milling Burs Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 79

The global CAD & CAM Milling Burs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ ......

Global Artificial Teeth Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 98

The global Artificial Teeth market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, a......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs